Werfen, S.A.

Werfen is a global developer and manufacturer of specialized diagnostic systems for clinical laboratories and hospitals worldwide. Founded in 1966 and headquartered in Barcelona, Spain, the company operates directly in 30 countries and serves over 100 territories through a global distribution network. Its primary product lines encompass in vitro diagnostic systems, reagents, data management solutions, and lab automation across Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant specialties. In Hemostasis and Acute Care Diagnostics, Werfen supplies comprehensive whole blood testing equipment and coagulation analyzers to improve clinical decision-making. The company's Autoimmunity and Transplant divisions deliver high-accuracy serology reagents, molecular assays, HLA testing platforms, and antibody-based diagnostic tools. Serving as a trusted partner to the global in vitro diagnostics industry, Werfen provides bulk assay supply, custom biomaterial development, recombinant antigens, and monoclonal antibodies. Additionally, Werfen offers value-added services including clinical trial support, international regulatory registration, contract manufacturing, and technical customer assistance. Supported by over 7,000 employees and state-of-the-art Technology Centers in Europe and the United States, Werfen continues to power patient care globally.